English
Technology & science
Limited Offer
Then 99 kr. / monthCancel anytime.
Myasthenia gravis, an autoimmune disease characterized by fluctuating muscle weakness, greatly impacts patients’ functioning and activities of daily living. Important treatment advances continue to be made to reduce patient burden of disease and overcome safety, efficacy, and other limitations of available therapies. Join Nicholas Silvestri, MD, as he reports on research results of some of these advances presented at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting.
Choose your subscription
Most popular
Limited Offer
Premium
20 hours of audiobooks
Podcasts only on Podimo
No ads in Podimo shows
Cancel anytime
1 month for 9 kr.
Then 99 kr. / month
Premium Plus
Unlimited audiobooks
Podcasts only on Podimo
No ads in Podimo shows
Cancel anytime
Start 7 days free trial
Then 129 kr. / month
1 month for 9 kr. Then 99 kr. / month. Cancel anytime.